Pradenas, Carolina
Luque-Campos, Noymar
Oyarce, Karina
Contreras-Lopez, Rafael
Bustamante-Barrientos, Felipe A.
Bustos, Andrés
Galvez-Jiron, Felipe
Araya, María Jesús
Asencio, Catalina
Lagos, Raúl
Herrera-Luna, Yeimi
Abba Moussa, Daouda
Hill, Charlotte Nicole
Lara-Barba, Eliana
Altamirano, Claudia
Ortloff, Alexander
Hidalgo-Fadic, Yessia
Vega-Letter, Ana María
García-Robles, María de los Ángeles
Djouad, Farida
Luz-Crawford, Patricia
Elizondo-Vega, Roberto
Funding for this research was provided by:
Agencia Nacional de Investigación y Desarrollo (fondecyt regular 1211353, IMPACT, #FB210024, fondecyt iniciacion 11190690)
Article History
Received: 12 June 2023
Accepted: 27 October 2023
First Online: 19 November 2023
Declarations
:
: All experiments involving animals were conducted according to the ethical policies and procedures approved by the ethics committee of the Faculty of Science, Universidad De Concepción, Chile (Approval number CEBB-532-2019; date of approval October 2019) and from the Ethics Committee of the School of Medicine at the Universidad de Los Andes in Santiago, Chile (Approval number CEC 2016309 addendum one; date of approval June 2019). The approved project is entitled “Monocarboxylate transporters and lactate receptor expression and function in proinflammatory lymphocytes plays a fundamental role in mesenchymal stem/stromal cells mediated immunosuppression” (Fondecyt iniciación grant number 11190690, principal investigator Roberto Elizondo-Vega) and the addendum that correspond to the ethical approval of the phD thesis project “ Study of the role of metabolism on the suppressive effect of umbilical cord-derived mesenchymal stem cells on memory T cells from rheumatoid arthritis patients”, related to Noymar Luque-Campos. All healthy donors signed the consent forms approved by the School of Medicine at the Universidad de Los Andes in Santiago, Chile (Approval number CEC 2016309 addendum one; date of approval June 2019).
: Not applicable.
: From October 2022 until June 2023, AMV was the scientific advisor of Innovacell-Chile. The other authors have declared that no competing interest exists.